Showing results (21-30 of 2,733) with videos related to
Sort By:
Pageof 274
Pharmacogenomics|September 24, 2010
Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patientsLaure Elens, Bernard Vandercam, Jean-Cyr Yombi, et al.Pharmacogenomics|September 24, 2010
Pharmacogenomics and active surveillance for serious adverse drug reactions in childrenTenneille T Loo, Colin J D Ross, Johanna Sistonen, et al.Pharmacogenomics|May 28, 2010
Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectivesBruno Vincenzi, Andrea Napolitano, Anna Maria Frezza, et al.Pharmacogenomics|May 28, 2010
HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysisSae-Hoon Kim, Myunghwa Kim, Kyung Wha Lee, et al.Pharmacogenomics|February 12, 2009
Family-based genome-wide association studiesBeben Benyamin, Peter M Visscher, Allan F McRaePharmacogenomics|November 5, 2010
CYP2C19*2 polymorphism is associated with increased survival in breast cancer patients using tamoxifenRikje Ruiter, Monique J Bijl, Ron H N van Schaik, et al.Pharmacogenomics|April 1, 2011
Risk modeling strategies for pharmacogenetic studiesAndrea L Jorgensen, Munir PirmohamedPharmacogenomics|April 1, 2011
Application of cost-effectiveness analysis to demonstrate the potential value of companion diagnostics in chronic myeloid leukemiaJennifer G Gaultney, Enrique Sanhueza, Jeroen J Janssen, et al.Pharmacogenomics|April 1, 2011
Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapyRobert H Goertsches, Uwe K Zettl, Michael HeckerPharmacogenomics|April 1, 2011
Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypesJatinder K Lamba, Kristine R Crews, Stanley B Pounds, et al.Pageof 274